Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Breast Neoplasms × bosutinib × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Philadelphia Chromosome 2 Translocation, Genetic 1 Pathologic Processes 1 Neoplasms by Histologic Type 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myeloid 1 Leukemia 1 Hematologic Diseases 1 Bronchiolitis Obliterans Syndrome 1 Bone Marrow Diseases 1 Blast Crisis 1

Interventions

Trastuzumab 6 Fulvestrant 6 Capecitabine 6 abemaciclib 5 trastuzumab deruxtecan 4 eribulin 4 Paclitaxel 4 Gemcitabine 4 sacituzumab govitecan 3 Vinorelbine 3 Docetaxel 3 Cyclophosphamide 3 selpercatinib 2 ribociclib 2 pertuzumab 2 olaparib 2 exemestane 2 Letrozole 2 Fluorouracil 2 Epirubicin 2 Doxorubicin 2 Anastrozole 2 Ado-Trastuzumab Emtansine 2 130-nm albumin-bound paclitaxel 2 tucatinib 1 talazoparib 1 palbociclib 1 neratinib 1 larotrectinib 1 inavolisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡